We have long studied immune treatment and response. For more than 15 years we studied colony stimulating factors (CSFs) and have published articles about immunotherapy. We also have studied the use of IVIg / SCIg to treat immunodeficient patients.
HIV / AIDS – Our firm’s scientists have done extensive research in the HIV / AIDS market for two decades, including several studies on AIDS-related infections.
MS – Our experience with multiple sclerosis extends back to the clinical internship in a Virginia state hospital of Clarity’s founder, Dr. Jack Gallagher, during which he worked with more than 100 MS patients and adults. Clarity since has studied various MS (and RRMS) treatments, including biologics, steroids, and interferons.
Psoriasis, Psoriatic Arthritis – We have conducted several studies on treatment algorithms (e.g., biologics vs. various other treatments) by location, severity, and efficacy.
RA – We have studied RA as well as important subpopulations of the disorder, e.g., RA patients with chronic kidney disease or anemia.
Other disease areas: dermatomyositis/polymyositis (DM/PM) and systemic lupus erythematosus (SLE)
Among devices and related products studied are intrathecal drug delivery systems (IDDS), intrauterine devices (IUDs), insulin delivery systems, imaging agents, genomic testing assays.
Immune disorders & deficiencies
Related Articles or Presentations